What types of vaginal discharge are there?

Vaginal discharge is a normal and important physiologic process for people with a vagina. It serves to cleanse the vagina, maintain a balanced microbial environment, provide lubrication, and protect against infection. However, changes in color, consistency, odor, volume, or accompanying symptoms can indicate an underlying condition requiring evaluation. This article describes the types of vaginal discharge, what each pattern commonly indicates, how clinicians evaluate discharge, management approaches for common causes, prevention strategies, and when to seek medical care. (Sources: ACOG, NIH/MedlinePlus, Mayo Clinic, Cleveland Clinic)

How vaginal discharge is produced and what is normal

Vaginal secretions result from cervical mucus, vaginal transudate, secretions from the vaginal epithelium, and microorganisms that normally live in the vagina. Estrogen and progesterone affect the quantity and quality of cervical mucus and vaginal epithelial shedding, producing predictable changes across the menstrual cycle. Normal discharge—often called leukorrhea—is usually clear or white, thin to slightly viscous, and typically odorless. It may increase in volume during ovulation, sexual arousal, pregnancy, and with hormonal contraception.

Physiologic changes:

  • Follicular phase (early cycle): low-volume, thin, slightly sticky or scant clear discharge.
  • Ovulation: increase in volume and elasticity; clear, slippery, "egg-white" appearance assists sperm transport.
  • Luteal phase (after ovulation): discharge often becomes thicker and white or creamy under progesterone influence.
  • Pregnancy: increased blood flow and estrogen cause greater overall volume of discharge; a change in color, odor, or onset of pain should be evaluated.
  • Menopause: decreased estrogen leads to decreased secretions and thinner, drier mucosa; atrophy may cause watery or blood-tinged discharge and irritation. (ACOG; Mayo Clinic)

Normal discharge generally:

  • Is clear to white or slightly yellow when old
  • Is odorless or has a mild non-offensive odor
  • Does not cause significant itching, burning, irritation, or pain

If discharge departs from these characteristics—particularly if it is accompanied by pruritus, burning, foul odor, pelvic pain, fever, or abnormal bleeding—clinical evaluation is warranted. (NIH/MedlinePlus; Cleveland Clinic)

Types of vaginal discharge by appearance and common causes

Below are common descriptions of discharge that patients and clinicians use, with typical associated causes and clinical clues.

Clear, stretchy, egg-white discharge

  • Description: Clear, slippery, elastic; may increase in quantity.
  • Timing: Most commonly at ovulation.
  • Likely cause: Normal physiologic cervical mucus during the fertile window.
  • Clinical notes: This discharge facilitates sperm mobility and is expected in reproductive-age individuals with regular cycles. No treatment is required unless other symptoms are present. (Mayo Clinic; ACOG)

Milky white or creamy discharge

  • Description: White or off-white, creamy, may be thicker than mid-cycle mucus.
  • Timing: Common in the mid-to-late luteal phase of the cycle; can occur with hormonal contraceptive use.
  • Likely cause: Physiologic response to progesterone; normal leukorrhea.
  • Clinical notes: If there is itchiness or clumping ("cottage-cheese" appearance), consider candidiasis (yeast infection). (Mayo Clinic)

Thick, curd-like (cottage-cheese) discharge with pruritus

  • Description: Thick, white, clumpy, often described as cottage-cheese–like.
  • Associated symptoms: Intense vulvar/vaginal itching, burning, irritation, dyspareunia (pain with intercourse), external redness.
  • Likely cause: Vulvovaginal candidiasis (Candida species).
  • Diagnostic clues: pH is typically normal (≤4.5); microscopy with potassium hydroxide (KOH) may show pseudohyphae or budding yeast; culture or molecular testing can confirm.
  • Treatment: Topical azole antifungals (clotrimazole, miconazole) or a single oral dose of fluconazole are standard options. Recurrent or complicated cases require gynecologic evaluation and possible longer-duration therapy. (Mayo Clinic; Cleveland Clinic)

Thin, grayish-white discharge with a fishy odor

  • Description: Thin, homogeneous, gray or off-white; often malodorous—especially after sexual activity.
  • Associated symptoms: May be minimal local irritation; odor is a key complaint.
  • Likely cause: Bacterial vaginosis (BV), an imbalance of vaginal flora with overgrowth of anaerobic bacteria and reduction of lactobacilli.
  • Diagnostic clues: Vaginal pH >4.5; presence of clue cells on saline microscopy; positive “whiff” (amine) test with KOH.
  • Treatment: Metronidazole (oral or intravaginal) or clindamycin (intravaginal) per guidelines. Sexual partners typically do not need treatment unless symptomatic; pregnant individuals with BV should be treated to reduce obstetric complications. (ACOG; NIH/MedlinePlus; Cleveland Clinic)

Frothy, yellow-green or gray-green discharge with odor and irritation

  • Description: Frothy, bubbly discharge that may be yellow-green in color.
  • Associated symptoms: Vaginal itching or irritation, discomfort with urination, dyspareunia, malodorous smell.
  • Likely cause: Trichomoniasis (Trichomonas vaginalis), a sexually transmitted protozoal infection.
  • Diagnostic clues: Wet mount microscopy may show motile trichomonads; nucleic acid amplification testing (NAAT) is more sensitive. Vaginal pH often >4.5.
  • Treatment: Single-dose or multi-dose metronidazole or tinidazole regimens; sexual partners require treatment to prevent reinfection. (CDC referenced by ACOG; Mayo Clinic)

Yellow, green, or purulent (pus-like) discharge

  • Description: Thick, often malodorous, yellow to green or purulent appearance.
  • Associated symptoms: Dysuria, pelvic discomfort, abnormal uterine bleeding, fever in advanced infections.
  • Likely cause: Cervicitis due to bacterial sexually transmitted infections such as Chlamydia trachomatis or Neisseria gonorrhoeae; abscess or pelvic inflammatory disease (PID) may also produce purulent cervical or uterine discharge.
  • Diagnostic clues: Cervical discharge on pelvic exam; NAAT testing for chlamydia and gonorrhea; cervical friability or mucopurulent exudate on speculum exam.
  • Treatment: Syndromic treatments and guideline-directed therapy for STIs (e.g., doxycycline plus ceftriaxone for PID; azithromycin or doxycycline for chlamydia per current recommendations). Partner notification and treatment are critical. (ACOG; CDC; NIH)

Brown or blood-tinged discharge

  • Description: Brown, rust-colored, or lightly blood-tinged discharge.
  • Timing/causes: May represent old menstrual blood, spotting between cycles (breakthrough bleeding), ovulatory bleeding, implantation bleeding in early pregnancy, or postmenopausal bleeding. Other causes include cervical polyps, trauma (e.g., after intercourse), infection, or less commonly, neoplasia.
  • Clinical notes: Any postmenopausal bleeding or new unexplained bleeding requires prompt evaluation (pelvic exam, pregnancy test, Pap/HPV testing, transvaginal ultrasound, endometrial sampling when indicated). (ACOG; Mayo Clinic)

Watery or increased-quantity clear discharge

  • Description: Increased volume of thin, watery clear discharge.
  • Causes: Normal physiologic leukorrhea, ovulation, pregnancy, or cervical ectropion. In some cases, it may suggest early rupture of membranes in pregnancy (rupture of membranes produces continuous watery leakage and requires urgent evaluation).
  • Clinical notes: In pregnancy, persistent watery leakage should prompt urgent assessment for membrane rupture. After menopause, watery discharge with irritation should raise concern for atrophic vaginitis or other pathology. (ACOG; NIH)

Foul-smelling or purulent discharge with fever and pelvic pain

  • Description: Malodorous, often brown or green discharge with systemic symptoms.
  • Associated symptoms: Pelvic pain, fever, nausea, malaise.
  • Likely causes: Pelvic inflammatory disease (ascending infection involving the uterus, fallopian tubes, and adnexa), tubo-ovarian abscess, severe cervicitis. These are potentially serious and require urgent medical treatment.
  • Management: Empiric broad-spectrum antibiotics and gynecologic/urgent care assessment; sometimes hospitalization. (ACOG; NIH)

How clinicians evaluate vaginal discharge

Evaluation is driven by history, physical examination, and targeted testing.

History

Important elements:

  • Onset, duration, and pattern of the discharge
  • Color, consistency, odor, and volume
  • Associated symptoms: itching, burning, pelvic pain, dysuria, abnormal bleeding
  • Menstrual cycle timing and recent tampon/pad/treatment use
  • Sexual activity and new or multiple partners
  • Contraceptive methods (IUDs, hormonal contraception)
  • Pregnancy status
  • Recent antibiotic use
  • Prior history of similar episodes and treatments

Physical examination

  • External inspection of the vulva for erythema, excoriations, fissures, or lesions.
  • Speculum examination to visualize cervical os and vaginal walls; note color and character of discharge; obtain swabs for testing.
  • Bimanual pelvic exam to assess for adnexal tenderness or masses (important when PID is suspected).

Bedside and laboratory testing

  • Vaginal pH: Normal ≤4.5. Elevated pH suggests BV or trichomoniasis.
  • KOH “whiff” test: Addition of potassium hydroxide to a vaginal sample producing an amine odor supports BV.
  • Saline wet mount microscopy: Allows visualization of clue cells (BV), motile trichomonads (trichomoniasis), and presence/absence of white blood cells or organisms.
  • KOH microscopy: May show budding yeast or pseudohyphae (candidiasis).
  • NAAT (nucleic acid amplification tests): High-sensitivity tests for chlamydia, gonorrhea, and trichomonas (preferred for many STI evaluations).
  • Vaginal culture: Less commonly needed for routine BV or yeast when testing resources are available; used in recurrent or complicated cases.
  • Pregnancy test: Blood or urine pregnancy test for any reproductive-age person with abnormal bleeding or discharge.
  • Cervical cytology (Pap/HPV testing) or direct visualization/biopsy if abnormal lesions or concern for neoplasia exist.
  • Imaging (ultrasound) or advanced labs if PID, tubo-ovarian abscess, or other pelvic pathology is suspected. (ACOG; NIH/MedlinePlus; Mayo Clinic)

Common causes and guideline-based management

Clinical management varies by diagnosis, severity, patient factors (including pregnancy), and local guidelines. Below are evidence-based, general approaches; definitive therapy should follow current clinical practice guidelines and clinician judgment.

Bacterial vaginosis (BV)

  • Cause: Polymicrobial shift with reduction in lactobacilli and overgrowth of anaerobic bacteria.
  • Symptoms: Thin gray discharge, fishy odor, often mild or no irritation.
  • Treatment: Oral metronidazole 500 mg twice daily for 7 days, or metronidazole 0.75% gel intravaginally once daily for 5 days, or clindamycin cream intravaginally. Alternative regimens for allergy or intolerance. Pregnant individuals with symptomatic BV should be treated; topical therapy may be considered. (ACOG; NIH/MedlinePlus)

Vulvovaginal candidiasis

  • Cause: Overgrowth of Candida species (most commonly Candida albicans).
  • Symptoms: Intense pruritus, thick white curd-like discharge, vulvar erythema.
  • Treatment: Topical azole antifungals (eg, clotrimazole, miconazole) for 1–7 days depending on formulation, or a single 150 mg oral dose of fluconazole for uncomplicated vulvovaginal candidiasis. Recurrent or severe cases require evaluation for predisposing factors (e.g., uncontrolled diabetes, immunosuppression) and longer-duration therapy. (Mayo Clinic; Cleveland Clinic)

Trichomoniasis

  • Cause: Trichomonas vaginalis, sexually transmitted.
  • Symptoms: Frothy green-yellow discharge, odor, vulvar irritation, sometimes dysuria.
  • Treatment: Metronidazole 500 mg orally twice daily for 7 days or 2 g orally once; tinidazole is an alternative. Treat sexual partners concurrently to prevent reinfection. (Mayo Clinic; CDC summarized in ACOG materials)

Cervicitis/chlamydia/gonorrhea

  • Cause: Sexually transmitted bacteria affecting the cervix; may produce mucopurulent cervical discharge.
  • Symptoms: Purulent cervical discharge, intermenstrual or postcoital bleeding, pelvic pain, dysuria.
  • Diagnosis: NAAT for chlamydia and gonorrhea. Microscopy less useful.
  • Treatment: Follow up-to-date STI treatment guidelines (e.g., ceftriaxone for gonorrhea plus doxycycline or azithromycin per current recommendations). Partner notification and treatment are essential. (ACOG; CDC guidelines referenced by ACOG)

Pelvic inflammatory disease (PID)

  • Cause: Ascending infection of the upper reproductive tract (can be polymicrobial).
  • Symptoms: Lower abdominal/pelvic pain, fever, cervical motion tenderness, abnormal discharge, possible systemic symptoms.
  • Management: Prompt empiric broad-spectrum antibiotics; severity-based outpatient vs inpatient therapy; evaluation for complications such as abscesses. Early treatment is critical to reduce long-term sequelae (infertility, chronic pelvic pain, ectopic pregnancy). (ACOG)

Foreign body and retained tampons

  • Cause: Retained foreign material (e.g., forgotten tampon or contraceptive device fragments) can produce malodorous, often purulent discharge and irritation.
  • Management: Pelvic exam, removal of the foreign body, and antibiotics if infection present. Education on proper tampon use and device follow-up. (Mayo Clinic)

Atrophic vaginitis (postmenopausal)

  • Cause: Estrogen deficiency leads to thinning of the vaginal epithelium, decreased secretions, and increased susceptibility to irritation and infection.
  • Symptoms: Vaginal dryness, watery discharge, spotting, dyspareunia.
  • Treatment: Topical vaginal estrogen (creams, rings, tablets) is effective for symptomatic atrophic vaginitis in individuals without contraindications; nonhormonal lubricants and moisturizers can also help. (ACOG; NIH)

Self-care, prevention, and lifestyle measures

  • Avoid douching: Douching disrupts the normal vaginal flora and is associated with increased risk of BV and other adverse outcomes. (ACOG; NIH)
  • Use unscented, breathable cotton underwear and avoid tight synthetic garments that trap moisture.
  • Practice safe sexual behaviors: Condom use reduces the transmission risk of many sexually transmitted infections. Limiting number of sexual partners and ensuring partners are treated for STIs when present reduces reinfection risk.
  • Avoid scented personal hygiene products and baths with fragrances in the genital area.
  • During menstruation, change tampons and pads regularly; do not leave tampons in longer than recommended.
  • Maintain good glucose control in diabetes to reduce the risk of recurrent fungal infections.
  • Be cautious with self-treatment for recurrent or atypical symptoms; when in doubt, seek medical evaluation. (Mayo Clinic; Cleveland Clinic; NIH)

Probiotic use:

  • Some individuals consider oral or vaginal probiotics containing Lactobacillus species to prevent recurrent BV; evidence is mixed. Discuss probiotic use with a clinician if recurrent problems persist. (NIH; evidence summarized in clinical reviews)

Special situations

Pregnancy

  • Physiologic: Increased estrogen and blood flow commonly increase vaginal discharge during pregnancy.
  • Pathologic: New onset of malodorous discharge, pruritus, purulence, pelvic pain, or watery leakage may indicate infection or ruptured membranes; prompt evaluation is essential. BV in pregnancy has been associated with preterm birth in some populations and treatment should be individualized per obstetric guidance. (ACOG; NIH)

Postpartum

  • Lochia: Postpartum vaginal discharge (lochia) is normal and evolves from red (lochia rubra) to pinkish-brown (lochia serosa) to yellow-white (lochia alba) over weeks. Foul odor, fever, or heavy bleeding suggests infection or retained products and requires evaluation. (ACOG)

Menopause and perimenopause

  • Atrophic changes can result in decreased secretions, dryness, and increased susceptibility to irritation and infection. Use of local vaginal estrogen may relieve symptoms when appropriate and safe for the patient. (ACOG)

Intrauterine devices (IUDs)

  • Some people with IUDs may have changes in bleeding patterns and, less commonly, an increase in discharge, particularly in the early months after insertion. New onset purulent discharge should be evaluated for possible device-associated infection. (Mayo Clinic)

When to see a healthcare provider

Seek medical attention promptly if any of the following occur:

  • Foul-smelling discharge, especially if new or persistent
  • Thick, white cottage-cheese discharge with severe itching or external redness
  • Green, yellow, or frothy discharge
  • New purulent or bloody discharge
  • Pelvic or lower abdominal pain, fever, or systemic symptoms
  • Painful urination, painful intercourse, or abnormal bleeding
  • Persistent or recurrent episodes despite over-the-counter treatments
  • Any abnormal discharge during pregnancy or postpartum
  • Any postmenopausal bleeding or new blood-tinged discharge

Early clinical assessment enables accurate diagnosis and timely treatment, reducing the risk of complications. (ACOG; Mayo Clinic; NIH)

Diagnostic red flags and urgent presentations

Seek urgent care or gynecologic consultation if discharge is accompanied by:

  • High fever, severe pelvic or abdominal pain, or dizziness (possible severe infection or abscess)
  • Heavy vaginal bleeding or hemodynamic instability
  • Suspected rupture of membranes in pregnancy (continuous watery leakage)
  • Signs suggestive of PID with systemic toxicity

Summary

Vaginal discharge is a normal physiologic process that varies with hormonal status, the menstrual cycle, sexual activity, and life stage (pregnancy, postpartum, menopause). Character changes—color, consistency, odor, volume—and associated symptoms such as itching, pain, fever, or bleeding are key indicators that help distinguish physiologic discharge from pathologic causes such as bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, cervicitis, and pelvic inflammatory disease. A structured clinical evaluation—including history, pelvic examination, pH testing, microscopy, and targeted laboratory testing—guides diagnosis and treatment. Preventive measures (avoiding douching, using breathable underwear, safe sexual practices) reduce the risk of some infections. When in doubt or when red-flag symptoms appear, timely evaluation by a healthcare professional is essential.

References and further reading

  • American College of Obstetricians and Gynecologists (ACOG). “Vaginitis.” Patient education and practice bulletins. https://www.acog.org
  • National Institutes of Health / MedlinePlus. “Vaginal Discharge.” https://medlineplus.gov/vaginaldischarge.html
  • Mayo Clinic. “Vaginal discharge: When to see a doctor.” https://www.mayoclinic.org/tests-procedures/vaginal-discharge/about/pac-20385214
  • Cleveland Clinic. “Bacterial Vaginosis,” “Yeast Infection (Vaginal Candidiasis),” “Trichomoniasis.” https://my.clevelandclinic.org

(Note: The above references summarize guidance from professional bodies and clinical resources. Treatment regimens and diagnostic approaches should follow current clinical guidelines and be individualized by a licensed healthcare provider.)